Mineralocorticoid receptor antagonism as an add-on treatment for resistant hypertension

被引：0
|
作者：
Rossi, Gian Paolo [1 ]
Maiolino, Giuseppe [1 ]
机构：
[1] Univ Padua, Dept Med DIMED, Padua, Italy
来源：
HYPERTENSION RESEARCH | 2014年 / 37卷 / 12期
关键词：
BLOOD-PRESSURE; SPIRONOLACTONE; PREVALENCE;
D O I：
10.1038/hr.2014.139
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：1029 / 1031
页数：3
相关论文
共 50 条
  • [41] Leukotriene receptor antagonists as first line or add-on treatment for asthma
    Ducharme, Francine M.
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
  • [42] The role of mineralocorticoid receptor function in treatment resistant depression
    Juruena, M. F.
    Cleare, A. J.
    Papadopoulos, A. S.
    Poon, L.
    Pariante, C. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S400 - S400
  • [43] Efficacy and tolerability of cenobamate as add-on treatment in drug-resistant epilepsy
    Wezyk, K.
    Wloch-Kopec, D.
    Bosak, M.
    EPILEPSIA, 2024, 65 : 174 - 174
  • [44] Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and the Metabolic Syndrome
    Pitt, Bertram
    HYPERTENSION, 2015, 65 (01) : 41 - 42
  • [45] Add-on therapy with pramipexole in treatment resistant dysthymic disorder: A case report
    Zeytinci, Esra
    Uguz, Faruk
    Sahingoz, Mine
    Sari, Serap
    Kayhan, Fatih
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 19 : S198 - S199
  • [46] Reboxetine utilization as add-on therapy to SSRI in treatment-resistant depression
    Tavormina, G
    Corea, S
    Citron, A
    Portici, P
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (11) : 1082 - 1082
  • [47] VIGABATRIN AS FIRST ADD-ON TREATMENT IN CARBAMAZEPINE-RESISTANT EPILEPSY PATIENTS
    MURRI, L
    IUDICE, A
    ACTA NEUROLOGICA SCANDINAVICA, 1995, 92 : 40 - 42
  • [48] Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study
    Otte, C.
    Hinkelmann, K.
    Moritz, S.
    Yassouridis, A.
    Jahn, H.
    Wiedemann, K.
    Kellner, M.
    PHARMACOPSYCHIATRY, 2009, 42 (05) : 234 - 234
  • [49] Temporary mineralocorticoid receptor antagonism during the development of hypertension improves cerebral artery dilation
    McClain, Jonathon L.
    Dorrance, Anne M.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2014, 239 (05) : 619 - 627
  • [50] Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy
    Hayakawa, Yuka
    Tamaki, Nobuharu
    Nakanishi, Hiroyuki
    Kurosaki, Masayuki
    Tanaka, Yuki
    Inada, Kento
    Ishido, Shun
    Kirino, Sakura
    Yamashita, Koji
    Nobusawa, Tsubasa
    Matsumoto, Hiroaki
    Kakegawa, Tatsuya
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Kaneko, Shun
    Yasui, Yutaka
    Takahashi, Yuka
    Tsuchiya, Kaoru
    Okamoto, Ryuichi
    Izumi, Namiki
    INTERNAL MEDICINE, 2023, 62 (07) : 973 - 978
12345